01 6Cubicin
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 152
2019 Revenue in Millions : 257
Growth (%) : -41
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2015 Revenue in Millions : 25
2014 Revenue in Millions : 1,127
Growth (%) : 4408%
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2016 Revenue in Millions : 1,087
2015 Revenue in Millions : 1,127
Growth (%) : -4
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2017 Revenue in Millions : 382
2016 Revenue in Millions : 1,087
Growth (%) : -65
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2018 Revenue in Millions : 367
2017 Revenue in Millions : 382
Growth (%) : -4%
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 257
2018 Revenue in Millions : 367
Growth (%) : -30
LOOKING FOR A SUPPLIER?